Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Panic disorder: treatment with valproate.

Woodman CL, Noyes R Jr.

J Clin Psychiatry. 1994 Apr;55(4):134-6.

PMID:
8071256
3.

Sertraline treatment of panic disorder: response in patients at risk for poor outcome.

Pollack MH, Rapaport MH, Clary CM, Mardekian J, Wolkow R.

J Clin Psychiatry. 2000 Dec;61(12):922-7.

PMID:
11206597
4.

A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder.

Lepola UM, Wade AG, Leinonen EV, Koponen HJ, Frazer J, Sjödin I, Penttinen JT, Pedersen T, Lehto HJ.

J Clin Psychiatry. 1998 Oct;59(10):528-34.

PMID:
9818634
5.

An open-label trial of nefazodone in high comorbidity panic disorder.

DeMartinis NA, Schweizer E, Rickels K.

J Clin Psychiatry. 1996 Jun;57(6):245-8.

PMID:
8666561
6.

A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.

Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B.

Depress Anxiety. 2007;24(1):1-14.

PMID:
16894619
7.

Divalproex sodium in substance abusers with mood disorder.

Albanese MJ, Clodfelter RC Jr, Khantzian EJ.

J Clin Psychiatry. 2000 Dec;61(12):916-21.

PMID:
11206596
8.

Long-term follow-up after a drug trial for panic disorder.

Katschnig H, Amering M, Stolk JM, Klerman GL, Ballenger JC, Briggs A, Buller R, Cassano G, Garvey M, Roth M, et al.

Br J Psychiatry. 1995 Oct;167(4):487-94.

PMID:
8829718
9.
10.

Adinazolam-SR in panic disorder with agoraphobia: relationship of daily dose to efficacy.

Carter CS, Fawcett J, Hertzman M, Papp LA, Jones W, Patterson WM, Swinson RP, Weise CC, Maddock RJ, Denahan AQ, et al.

J Clin Psychiatry. 1995 May;56(5):202-10.

PMID:
7737960
11.

Valproate treatment of panic disorder and lactate-induced panic attacks.

Keck PE Jr, Taylor VE, Tugrul KC, McElroy SL, Bennett JA.

Biol Psychiatry. 1993 Apr 1;33(7):542-6.

PMID:
8513040
12.

Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients.

Asnis GM, Hameedi FA, Goddard AW, Potkin SG, Black D, Jameel M, Desagani K, Woods SW.

Psychiatry Res. 2001 Aug 5;103(1):1-14.

PMID:
11472786
13.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
14.

Fluoxetine efficacy in social phobia.

Van Ameringen M, Mancini C, Streiner DL.

J Clin Psychiatry. 1993 Jan;54(1):27-32.

PMID:
8428894
15.

An open trial of valproate in borderline personality disorder.

Stein DJ, Simeon D, Frenkel M, Islam MN, Hollander E.

J Clin Psychiatry. 1995 Nov;56(11):506-10.

PMID:
7592502
17.

Plasma alprazolam concentrations. Relation to efficacy and side effects in the treatment of panic disorder.

Greenblatt DJ, Harmatz JS, Shader RI.

Arch Gen Psychiatry. 1993 Sep;50(9):715-22.

PMID:
8357297
18.

An open-label trial of risperidone augmentation for refractory anxiety disorders.

Simon NM, Hoge EA, Fischmann D, Worthington JJ, Christian KM, Kinrys G, Pollack MH.

J Clin Psychiatry. 2006 Mar;67(3):381-5.

PMID:
16649823
19.
20.

A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder.

Hollander E, Allen A, Lopez RP, Bienstock CA, Grossman R, Siever LJ, Merkatz L, Stein DJ.

J Clin Psychiatry. 2001 Mar;62(3):199-203.

PMID:
11305707
Items per page

Supplemental Content

Write to the Help Desk